VB 517
Alternative Names: NN-2802; SLRN-517; VB-517Latest Information Update: 22 Aug 2024
At a glance
- Originator Novelty Nobility
- Developer ACELYRIN; Novelty Nobility
- Class Monoclonal antibodies; Skin disorder therapies
- Mechanism of Action Proto-oncogene protein c-kit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chronic urticaria; Mastocytosis